Titan Company Limited - 500114 - Board Meeting Intimation for Considering And Approve The Unaudited Financial Results For The Quarter And Half Year Ended 30Th September 2020.
Titan Company Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/10/2020 ,inter alia, to consider and approve the unaudited financial results for the quarter and half year ended 30th September 2020. Titan Company Limited - 500114 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of Analyst / Institutional Investor Meetings Titan Company Limited - 500114 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation towards loss of Share Certificate a under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Titan Company Limited - 500114 - Announcement under Regulation 30 (LODR)-Cessation
Change of Director - Resignation of Ms. Ireena Vittal as an Independent Director
Brokerages place bets on Titan, see double-digit upside in the stock
Titan can get benefits from the strong market share in the jewellery and wrist watches segment, mainly driven by a wide range of product portfolio catering mainly to the premium and value-added designer jewellery segment. Titan Company Limited - 500114 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of Analyst / Institutional Investor Meetings Titan Company Limited - 500114 - Closure of Trading Window
Intimation of Closure of Trading Window Titan ticks with Covid times to roll out contactless payments watches
Titan Pay range, launched in tie-up with SBI, allows bank's YONO account holders to tap the watch on contactless payment POS machines without having to swipe or insert bank card\ Titan Company Limited - 500114 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of Analyst / Institutional Investor Meetings Titan Company Limited - 500114 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of Analyst / Institutional Investor Meetings